UKADC Workshop for System Partners

April 3rd, Wellcome Collection, London

The UK Antimicrobial Diagnostics Collaborative (UKADC), would like to extend an invitation to system partners with a role in the innovation and adoption of rapid diagnostics

Over the last year the UKADC has worked collaboratively with partners across the health system to shape the role of rapid diagnostics in the government response to the AMR challenge.  As part of our stakeholder engagement process we have undertaken a two part process for industry engagement. The first chapter is to liaise with the rapid diagnostic industry sector to capture the challenges and for them to share potential solutions.  The second chapter is to share these findings with health system partners and to stress test industry outputs against the rapid diagnostic system landscape.

The day will provide a workshop, to be held at The Wellcome Collection, London, designed to understand how health system partners in regulation, policy innovation, funding, quality, safety and research currently function and how the system can support AMR Rapid Diagnostics ambition to embed rapid diagnostics as part of the government response to the global challenge of AMR

The UK AMR diagnostic collaborative has undertaken a series of engagement events to gain an understanding from industry and industry representatives on:

·        The current challenges when accelerating usage of solutions manufactured by industry

·        The challenges and potential solutions to feed into national policy

·        Highlight opportunities for test bed working

The culmination in the series of events is to meet with system partners to understand how health system partners in regulation, policy innovation, funding, quality, safety and research can support the governments ambition to embed rapid diagnostics in clinical decision making as part of the UK response to the global challenge of AMR.

 

  • Please note this workshop is strictly for those professionals involved within the system of Rapid Diagnostic Policy and Regulation.

Name *
Name